Literature DB >> 26521295

The origin of relapse in pediatric T-cell acute lymphoblastic leukemia.

Carmen Vicente1, Jan Cools2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26521295      PMCID: PMC4825310          DOI: 10.3324/haematol.2015.136077

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  13 in total

1.  Pediatric T-cell lymphoblastic leukemia evolves into relapse by clonal selection, acquisition of mutations and promoter hypomethylation.

Authors:  Joachim B Kunz; Tobias Rausch; Obul R Bandapalli; Juliane Eilers; Paulina Pechanska; Stephanie Schuessele; Yassen Assenov; Adrian M Stütz; Renate Kirschner-Schwabe; Jana Hof; Cornelia Eckert; Arend von Stackelberg; Martin Schrappe; Martin Stanulla; Rolf Koehler; Smadar Avigad; Sarah Elitzur; Rupert Handgretinger; Vladimir Benes; Joachim Weischenfeldt; Jan O Korbel; Martina U Muckenthaler; Andreas E Kulozik
Journal:  Haematologica       Date:  2015-08-20       Impact factor: 9.941

2.  The activating STAT5B N642H mutation is a common abnormality in pediatric T-cell acute lymphoblastic leukemia and confers a higher risk of relapse.

Authors:  Obul R Bandapalli; Stephanie Schuessele; Joachim B Kunz; Tobias Rausch; Adrian M Stütz; Noa Tal; Ifat Geron; Nava Gershman; Shai Izraeli; Juliane Eilers; Nina Vaezipour; Renate Kirschner-Schwabe; Jana Hof; Arend von Stackelberg; Martin Schrappe; Martin Stanulla; Martin Zimmermann; Rolf Koehler; Smadar Avigad; Rupert Handgretinger; Viktoras Frismantas; Jean Pierre Bourquin; Beat Bornhauser; Jan O Korbel; Martina U Muckenthaler; Andreas E Kulozik
Journal:  Haematologica       Date:  2014-06-27       Impact factor: 9.941

3.  Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87.

Authors:  Hagen Graf Einsiedel; Arend von Stackelberg; Reinhard Hartmann; Rüdiger Fengler; Martin Schrappe; Gritta Janka-Schaub; Georg Mann; Karel Hählen; Ulrich Göbel; Thomas Klingebiel; Wolf-Dieter Ludwig; Günter Henze
Journal:  J Clin Oncol       Date:  2005-11-01       Impact factor: 44.544

4.  The genetic basis of early T-cell precursor acute lymphoblastic leukaemia.

Authors:  Jinghui Zhang; Li Ding; Linda Holmfeldt; Gang Wu; Sue L Heatley; Debbie Payne-Turner; John Easton; Xiang Chen; Jianmin Wang; Michael Rusch; Charles Lu; Shann-Ching Chen; Lei Wei; J Racquel Collins-Underwood; Jing Ma; Kathryn G Roberts; Stanley B Pounds; Anatoly Ulyanov; Jared Becksfort; Pankaj Gupta; Robert Huether; Richard W Kriwacki; Matthew Parker; Daniel J McGoldrick; David Zhao; Daniel Alford; Stephen Espy; Kiran Chand Bobba; Guangchun Song; Deqing Pei; Cheng Cheng; Stefan Roberts; Michael I Barbato; Dario Campana; Elaine Coustan-Smith; Sheila A Shurtleff; Susana C Raimondi; Maria Kleppe; Jan Cools; Kristin A Shimano; Michelle L Hermiston; Sergei Doulatov; Kolja Eppert; Elisa Laurenti; Faiyaz Notta; John E Dick; Giuseppe Basso; Stephen P Hunger; Mignon L Loh; Meenakshi Devidas; Brent Wood; Stuart Winter; Kimberley P Dunsmore; Robert S Fulton; Lucinda L Fulton; Xin Hong; Christopher C Harris; David J Dooling; Kerri Ochoa; Kimberly J Johnson; John C Obenauer; William E Evans; Ching-Hon Pui; Clayton W Naeve; Timothy J Ley; Elaine R Mardis; Richard K Wilson; James R Downing; Charles G Mullighan
Journal:  Nature       Date:  2012-01-11       Impact factor: 49.962

5.  Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study.

Authors:  K Nguyen; M Devidas; S-C Cheng; M La; E A Raetz; W L Carroll; N J Winick; S P Hunger; P S Gaynon; M L Loh
Journal:  Leukemia       Date:  2008-09-25       Impact factor: 11.528

Review 6.  Biology of childhood acute lymphoblastic leukemia.

Authors:  Luca Lo Nigro
Journal:  J Pediatr Hematol Oncol       Date:  2013-05       Impact factor: 1.289

7.  Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia.

Authors:  Charles G Mullighan; Letha A Phillips; Xiaoping Su; Jing Ma; Christopher B Miller; Sheila A Shurtleff; James R Downing
Journal:  Science       Date:  2008-11-28       Impact factor: 47.728

8.  Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia.

Authors:  Kim De Keersmaecker; Zeynep Kalender Atak; Ning Li; Carmen Vicente; Stephanie Patchett; Tiziana Girardi; Valentina Gianfelici; Ellen Geerdens; Emmanuelle Clappier; Michaël Porcu; Idoya Lahortiga; Rossella Lucà; Jiekun Yan; Gert Hulselmans; Hilde Vranckx; Roel Vandepoel; Bram Sweron; Kris Jacobs; Nicole Mentens; Iwona Wlodarska; Barbara Cauwelier; Jacqueline Cloos; Jean Soulier; Anne Uyttebroeck; Claudia Bagni; Bassem A Hassan; Peter Vandenberghe; Arlen W Johnson; Stein Aerts; Jan Cools
Journal:  Nat Genet       Date:  2012-12-23       Impact factor: 38.330

9.  Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL.

Authors:  Gannie Tzoneva; Arianne Perez-Garcia; Zachary Carpenter; Hossein Khiabanian; Valeria Tosello; Maddalena Allegretta; Elisabeth Paietta; Janis Racevskis; Jacob M Rowe; Martin S Tallman; Maddalena Paganin; Giuseppe Basso; Jana Hof; Renate Kirschner-Schwabe; Teresa Palomero; Raul Rabadan; Adolfo Ferrando
Journal:  Nat Med       Date:  2013-02-03       Impact factor: 53.440

10.  Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia.

Authors:  Julia A Meyer; Jinhua Wang; Laura E Hogan; Jun J Yang; Smita Dandekar; Jay P Patel; Zuojian Tang; Paul Zumbo; Sheng Li; Jiri Zavadil; Ross L Levine; Timothy Cardozo; Stephen P Hunger; Elizabeth A Raetz; William E Evans; Debra J Morrison; Christopher E Mason; William L Carroll
Journal:  Nat Genet       Date:  2013-02-03       Impact factor: 38.330

View more
  4 in total

1.  Pediatric T-ALL type-1 and type-2 relapses develop along distinct pathways of clonal evolution.

Authors:  Paulina Richter-Pechańska; Joachim B Kunz; Tobias Rausch; Büşra Erarslan-Uysal; Beat Bornhauser; Viktoras Frismantas; Yassen Assenov; Martin Zimmermann; Margit Happich; Caroline von Knebel-Doeberitz; Nils von Neuhoff; Rolf Köhler; Martin Stanulla; Martin Schrappe; Gunnar Cario; Gabriele Escherich; Renate Kirschner-Schwabe; Cornelia Eckert; Smadar Avigad; Stefan M Pfister; Martina U Muckenthaler; Jean-Pierre Bourquin; Jan O Korbel; Andreas E Kulozik
Journal:  Leukemia       Date:  2022-05-18       Impact factor: 12.883

2.  Ginsenoside Rh2 and Rg3 inhibit cell proliferation and induce apoptosis by increasing mitochondrial reactive oxygen species in human leukemia Jurkat cells.

Authors:  Ting Xia; Ying-Nan Wang; Chuan-Xin Zhou; Li-Mei Wu; Yong Liu; Qian-Hong Zeng; Xiang-Long Zhang; Jia-Hui Yao; Min Wang; Jian-Pei Fang
Journal:  Mol Med Rep       Date:  2017-04-11       Impact factor: 2.952

3.  Controversial Flow Cytometry Monitoring of a Relapse Case of Pediatric T Cell Acute Lymphoblastic Leukemia: A Case Report.

Authors:  Delia Codruţa Popa; Andreea Şerbănică; Radu Obrisca; Ionut Şerbănică; Letiţia Radu; Cristina Jercan; Andra Marcu; Ana Bica; Minodora Asan; Mădălina Petran; Mihaela Dragomir; Cerasela Jardan; Valeria Ţică; Anca Gheorghe; Irina Stoian; Daniel Coriu; Anca Coliţă; Andrei Coliţă
Journal:  Front Med (Lausanne)       Date:  2022-03-22

Review 4.  Deregulation of the Interleukin-7 Signaling Pathway in Lymphoid Malignancies.

Authors:  Inge Lodewijckx; Jan Cools
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.